Literature DB >> 16007751

A cost analysis of participation via personal attendance versus telemedicine at a head and neck oncology multidisciplinary team meeting.

Joacim Stalfors1, Ingela Björholt, Thomas Westin.   

Abstract

Multidisciplinary team (MDT) meetings are used for establishing diagnosis, for tumour, node, metastasis (TNM) classification and for treatment in head and neck tumour patients in the western region of Sweden. Because of the distances, telemedicine was introduced to link the regional hospital to two of the three district general hospitals (DGHs). We evaluated the costs of presenting patients face to face (FTF) versus via telemedicine. Cost analyses were based on questionnaires completed by patients presented at the MDT meeting. A total of 39 patients were included in the FTF group and 45 patients in the telemedicine group. The cost analysis showed that FTF presentation cost SEK 2267 versus SEK 2036 by telemedicine (difference not significant). The small difference was explained by the fact that the responsible physician accompanied only six of 39 patients when presented FTF, but when presented via telemedicine the DGH physician always participated. A sensitivity analysis revealed that if the responsible physician always accompanied his/her patient for presentation FTF, the cost would be SEK 5366 per patient. This study shows that costs may be saved by carrying out MDT meetings by means of telemedicine instead of FTF.

Entities:  

Mesh:

Year:  2005        PMID: 16007751     DOI: 10.1258/1357633054068892

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  17 in total

1.  A prospective study of the clinical impact of a multidisciplinary head and neck tumor board.

Authors:  Stephen A Wheless; Kibwei A McKinney; Adam M Zanation
Journal:  Otolaryngol Head Neck Surg       Date:  2010-11       Impact factor: 3.497

2.  Multidisciplinary team a prerequisite in the management of head and neck cancer?

Authors:  Jan Olofsson
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-02       Impact factor: 2.503

3.  How effective is video consultation in clinical oncology? A systematic review.

Authors:  C Kitamura; L Zurawel-Balaura; R K S Wong
Journal:  Curr Oncol       Date:  2010-06       Impact factor: 3.677

Review 4.  The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer.

Authors:  Paolo Bossi; Salvatore Alfieri
Journal:  Curr Treat Options Oncol       Date:  2016-10

5.  Development of a virtual multidisciplinary lung cancer tumor board in a community setting.

Authors:  Marvaretta M Stevenson; Tonia Irwin; Terry Lowry; Maleka Z Ahmed; Thomas L Walden; Melanie Watson; Linda Sutton
Journal:  J Oncol Pract       Date:  2013-05       Impact factor: 3.840

Review 6.  The economic burden of head and neck cancer: a systematic literature review.

Authors:  Erika Wissinger; Ingolf Griebsch; Juliane Lungershausen; Talia Foster; Chris L Pashos
Journal:  Pharmacoeconomics       Date:  2014-09       Impact factor: 4.981

7.  Wheelchair Seating Assessment and Intervention: A Comparison Between Telerehabilitation and Face-to-Face Service.

Authors:  Ingrid G Barlow; Lili Liu; Angela Sekulic
Journal:  Int J Telerehabil       Date:  2009-09-04

8.  Are multidisciplinary teams in secondary care cost-effective? A systematic review of the literature.

Authors:  K Melissa Ke; Jane M Blazeby; Sean Strong; Fran E Carroll; Andy R Ness; William Hollingworth
Journal:  Cost Eff Resour Alloc       Date:  2013-04-04

Review 9.  Overcoming distance: video-conferencing as a clinical and educational tool among surgeons.

Authors:  Knut Magne Augestad; Rolv Ole Lindsetmo
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

10.  A study of the decision outcomes and financial costs of multidisciplinary team meetings (MDMs) in oncology.

Authors:  P B De Ieso; J I Coward; I Letsa; U Schick; M Nandhabalan; S Frentzas; M E Gore
Journal:  Br J Cancer       Date:  2013-10-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.